Genetics 7 Flashcards

(52 cards)

1
Q

Describe the characteristics of monogenic disease

A

Monogenic disease: one mutation

Monogenic disease: one gene, many mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the characteristics of polygenic disease

A

Multigenic disease: many genes, many mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the principles of a DNA test

A

DNA isolation

PCR (amplification of selected DNA region) + digestion, if needed

Visualisation of result on an agarose gel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the use of PCR in the diagnosis of cystic fibrosis

A

PCR with primers that span region of CFTR gene for 3bp deletion that results in ΔF508
The mutant product is 3 nucleotides shorter than the normal product.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How can we use PCR to detect single nucleotide changes

A

PCR- amplify products
Use specific restriction endonucleases that cleave the DNA at specific sites ( the site of a mutation)
New fragment in homozygote phenotype of disease
new fragment + normal fragment in heterozygote phenotype.
This is known as Restriction Fragment Length Polymorphism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe PCR multiplexing

A

Allele-specific PCR
Mutation specific primers: Primers bind to mutant DNA- oligonucleotides and DNA ligase are used to join the two primers- creating a PCR amplifiable molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do we do if we don’t know the mutation

A

We sequence all of the exons in the gene- Snager sequencing to look for point mutations in the gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does sanger sequencing work

A

Single-stranded PCR product
Add primer, DNA polymerase and 4 didieoxy nucloetides
When they bind to the template strand by complementary base pairing, they terminate the growing chain as they have no 3’-OH group.
The bases are tagged with a specific colour
The fragments each ending in a different base are separated by capillary electrophoresis- to get size order
Chromatogram reads the colour of each fragment
Sequence is determined

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why is it important to get the right amount of chain terminators.

A

More terminator A than A:
Strand would stop growing at a specific base length, and so would accumulate
Bands of certain base lengths would not be synthesised.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the pros and cons of Sanger Sequencing

A

Pros ; Low error rate, long read length
Cons: Expensive, need a lot of DNA to start, Can only do 1 sequence at a time, can only do one forwards and one reverse reads.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the pros and cons of Next Generation sequencing

A

Pros- fast turnaround time, massively parallel (millions of fragments can be sequenced in a single run), cheaper.
Cons: Short read length, fewer reads of each bases are combined, so less accurate overall.
Not targeted- unlike Sanger sequencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the process of Next Generation Sequencing

A

Genomic DNA from the patient is fragmented, denatured and exposed to a cocktail of probes that represent desired sequences to check. The hybridizing fragments are isolated and used for sequencing.
The fragments are then aligned to a reference genome
Sequences line up, same base as that of reference, may line up but be different base- heterozygote

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the importance of long read lengths

A

In order to make sense of the myriad of short reads generated, they must be aligned to the reference genome, the shorter the individual reads, the harder it is to align them unambiguously, especially in repetitive regions of the genome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the importance of read depths

A

To distinguish true variants from random sequencing errors. Hence, we need a large number of independent reads across any genomic position. If there are only two good reads, one G and one A, impossible to know which one is a true variation or sequence error. 14As and 1G- obvious. 9As and 6Gs- heterozygous.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the different library preparations

A
Genomic – DNA
Whole genome
Targetted
Exome sequencing (1% genome)
Gene panels
Epigenome (DNA methylation sites)
Transcriptomic – (polyA) mRNA
Short regulatory RNA
Protein bound regions
Transcription factors
Protein-mRNA interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the difference between whole genome and targeted capture

A

Whole genome- sequence whole genome to get target gene output from one flow cell
Targeted- enrich targeted DNA- output from one lane flow
This is cheaper.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are gene panels used for

A

Sequence selected sets of genes:
Multigenic diseases, e g Primary Ciliary Dyskinesia (PCD)
Mutations identified in 37 genes -> commercial gene panel
Detects 80% of mutations
300 candidate genes with an identified role in ciliogenesis -> gene panel for identification of novel mutations
Population specific gene panels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the purpose of epigenome analysis

A

To see which parts of the genome are active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe how we analyse the epigenome

A

Treat the DNA with bisulfite under carefully controlled conditions.
Bisulfite converts unmethylated cytosines into uracil by deamination.
Hybridise
Amplify by PCR
Sequence by NGS or Sanger Sequencing
Every unmethylated C will appear as a T, allowing us to analyse methylation patterns.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the purpose of analysing the transcriptome

A

Which genes are active in cell/tissue?
Gene expression differences in healthy/affected tissue
-> Biological pathways involved in disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Can RNA be cloned, amplified or sequenced

22
Q

Describe how we analyse the transcriptome

A

Collect sample of mRNA
Convert into cDNA using reverse transcriptase
Amplify by RT-PCR- using specific primers.

23
Q

What is the difficulty of using RNA

A

RNA is harder to obtain and handle than DNA.
Mutant genes often produce no detectable mRNA.
RNA is unstable, requiring stringent conditions in the laboratories- need special reagents to stabilise RNA.
Only expressed in specific tissues.

24
Q

What is the purpose of short regulatory RNA, miRNA sequencing

A

Which genes are silenced by short interfering RNA?

Identification of regulatory miRNA for gene silencing e.g oncogenes

25
Describe how we analyse the Regulatory RNA genome
Use samples of miRNAs from library. Bind it to specific mRNA If complementary, no translation, allowing us to sequence the miRNA.
26
What is the purpose of analysing protein bound regions
Which genomic regions regulate gene expression? Transcription factors Protein-mRNA interactions
27
Why is it useful to test for proteins
If a disease is caused by the absence of a particular protein, which could be caused by a vast amount of mutations, it may be better to test directly for protein rather than analysing the whole gene looking for mutations. However in practice, this is not as simple, protein tests are specific, whereas DNA tests are generic.
28
How do we test for protein bound regions
Crosslink and purification of protein bound DNA ChIP: Enrichment of DNA with protein specific antibody DNA purification and sequencing.
29
Describe the method, output, cost, advantages and disadvantages of PCR
``` Amplification of region using specific primers Present vs absentSize of fragment Low cost QuickCan have variants Can multiplex Relies on primer sites not being mutated Does not give sequence ```
30
Describe the method, output, cost, advantages and disadvantages of Sanger Sequencing
Amplification of region of interest with nucleoside terminators Genetic sequence of specific region of interest Intermediate cost QuickGives sequence Cannot multiplex (easily) Limited to 2000 bp maximum (ideally 250-1000bp)
31
Describe the method, output, cost, advantages and disadvantages of NGS
Fragmentation, sequencing and mapping of reads Sequence of genome/ transcriptome/translatome/microbiome High cost Massively multiplexMultiple different library preparations Cost Time Read-depth Library biases Data overload
32
What is personalised medicine
use of genomics to tailor medical care to individuals based on their genetic make-up.
33
How could personalised medicine be utilised
``` Discovery- elucidations of mechanisms of cause, identification of cancer biomarkers, therapeutic targets Diagnosis- Is it Benign? Classification- Which class of cancer? Prognosis- What are my chances? Therapeutic choice- Optimal treatments? ```
34
Describe large-scale genomic projects
``` 100,000 genomes project 50,000 from cancer patients 2 per patient 50,000 for rare diseases 1 per patient and 2 blood relatives Identify genomic signatures for rare diseases Diagnosis Hypothesis generation Can use NHS/PHE data to do large scale genotype-phenotype studies ```
35
Describe the use of NGS in the rapid diagnosis of infectious diseases
16S rRNA sequencing for bacteria Whole viral sequencing Rapid diagnosis ``` Purify DNA from biofilm PCR amplify 16S rRNA gene Sequence PCR product Compare sequence to database Identify bacterial species. ```
36
Describe the basic principles of nanopore technologies such as MinION
DNA can be sequences by threading it through a microscopic pore in a membrane. Bases are identified by the way they effect the flow of ions through the pore.
37
Describe how MinION can be used to sequence DNA
One protein unzips the DNA helix into two strands A second protein creates the pore in the membrane and holds an 'adaptor' molecule. A flow of ions through the pore creates a current. Each base blocks the flow of ions to a different degree, altering the current. The adaptor molecules keeps bases in place long enough for them to be identified electronically.
38
Describe the advantage of MinION
It is portable
39
What are the different methods of gene therapy
``` Gene delivery Targeted genome editing Read through oligonucleotides Silencing non-sense mediated decay (NMD) miRNA ```
40
Describe the direct delivery of a gene
Treatment or missing gene is added to a vector, such as an adeno-assisted virus, which is delivered directly to the patient via an injection.
41
Describe the cell-based delivery of a gene
The patient's own stem cells are removed from the body and are cultured. The treatment or missing gene is added to a harmless retrovirus or lentivirus Which in turn introduces it into the patients stem cells- sequenced to see if they have taken up the gene Returned to the patient.
42
Describe CAR T cells and their role
Chimeric antigen receptors, antigen-binding and T-cell activating functions modified T cells to recognize cancer cells Specific to tumor antigens
43
Describe the results of CAR T therapy
Study of acute lymphoblastic leukaemia (ALL) patients showed 94% of success rate (no symptoms) Other blood cancers show 80% response rate, >50% of complete remission A living drug, can stay in the body for life Dangerous side effects: cytokine release syndrome (sCRS) -> Modification of T cells by CRISPR/Cas9
44
Describe, simply, how CRISPR/Cas9 works
A cell is transfected with an enzyme complex containing: Guide molecule, healthy DNA copy, DNA cutting enzyme. A specially designed synthetic guide molecule finds the target DNA strand, An enzyme cuts off the target DNA strand Replaced by healthy copy of DNA.
45
What are the challenges of gene therapy
Delivering the gene to the right place and switching it on Avoiding the immune response Making sure the new gene doesn’t disrupt the function of other genes, off target effects interferes with an important gene involved in regulating cell division -> cancer Size of delivered constructs The cost of gene therapy Maintaining long lasting and adequate levels of the introduced gene.
46
What is read through therapy
Treating disease by inserting premature stop codons- Release factors required.
47
Describe nonsense suppression therapy
Degradation of RNA by nonsense mediated decay (NMD) can be overcome by NMD inhibitors Mutations in tumor suppressor genes (e.g. PTC) leading to NMD Protein production is increased by NMD inhibitors
48
Describe mRNA therapeutics
Delivery into the cytoplasm, no need to access the nucleus Highly unstable and rapidly degraded Strongly stimulates the innate immune system inducing an extremely powerful inflammatory response. -> Development of ways to stabilize RNA and delivery systems, nanoparticles Does not integrate into the genome
49
Describe the use of small RNA therapy to treat cancers
DNA, mRNA and miRNA profiling. Target validation In vivo delivery Chemotherapy, small RNA therapy to silence genes.
50
Describe miRNA therapeutics
Different functions of miRNAs -> research needed to understand the interaction networks Several preclinical and clinical studies Toxicity, stability Delivery!
51
What are the challenges of genomic medicine
``` Cost Ethics NGS Who should have access to NGS data? What safeguards should be in place re: patient counselling Bioinformatics Therapeutics Toxicity Long term effects Off target effects ```
52
What are the three aspects of personalised medicine
1. Precision diagnostics. upwards of 20% of medical advice is incorrect. 2. Tailored therapeutics. Your treatment can be customized to suit your genetic profile. Drugs work very differently in some people, and the individual’s genome is the best source of information about treatment response and tolerability. over half of all cancer drugs have a specific molecular target. 3. Genetic risk assessment. Instead of waiting for a disease to occur and then reacting, we could be proactive. Genome sequencing has the potential to create a healthcare system that is predictive, preventive, and personalized.